We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Testosterone MDL Judge Picks 1st 8 AndroGel Bellwether Cases

(August 5, 2016, 11:57 AM EDT) -- CHICAGO — The Illinois federal judge overseeing the testosterone multidistrict litigation on Aug. 4 identified eight AbbVie heart attack, stroke and blood clot cases for the MDL’s first bellwether trials starting next year (In Re: Testosterone Replacement Therapy Products Liability Litigation, MDL Docket No. 2545, No. 14-1748, N.D. Ill., Eastern Div.).

(Order available. Document #28-160818-002R.)

U.S. Judge Matthew F. Kennelly of the Northern District of Illinois said the first four cases will involve plaintiff claims that AbbVie’s AndroGel caused myocardial infraction or stroke and the second...
To view the full article, register now.